These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32264333)

  • 21. Dual targeted zeolitic imidazolate framework nanoparticles for treating metastatic breast cancer and inhibiting bone destruction.
    Shen Y; Lv Y
    Colloids Surf B Biointerfaces; 2022 Nov; 219():112826. PubMed ID: 36115265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate-targeted nanostructured chitosan/chondroitin sulfate complex carriers for enhanced delivery of bortezomib to colorectal cancer cells.
    Soe ZC; Poudel BK; Nguyen HT; Thapa RK; Ou W; Gautam M; Poudel K; Jin SG; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
    Asian J Pharm Sci; 2019 Jan; 14(1):40-51. PubMed ID: 32104437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Chemo-Photothermal Therapy in Breast Cancer Using Methotrexate-Loaded Folic Acid Conjugated Au@SiO
    Agabeigi R; Rasta SH; Rahmati-Yamchi M; Salehi R; Alizadeh E
    Nanoscale Res Lett; 2020 Mar; 15(1):62. PubMed ID: 32189075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44-targeting hyaluronic acid-selenium nanoparticles boost functional recovery following spinal cord injury.
    Luo W; Li Y; Zhao J; Niu R; Xiang C; Zhang M; Xiao C; Liu W; Gu R
    J Nanobiotechnology; 2024 Jan; 22(1):37. PubMed ID: 38263204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer.
    Liang Y; Wang Y; Wang L; Liang Z; Li D; Xu X; Chen Y; Yang X; Zhang H; Niu H
    Bioact Mater; 2021 Feb; 6(2):433-446. PubMed ID: 32995671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of structurally modifying hyaluronic acid on CD44 interaction.
    Bhattacharya D; Svechkarev D; Souchek JJ; Hill TK; Taylor MA; Natarajan A; Mohs AM
    J Mater Chem B; 2017; 5(41):8183-8192. PubMed ID: 29354263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel treatment modality for rheumatoid arthritis: Inflammation-targeted multifunctional metal-organic frameworks with synergistic phototherapy and chemotherapy.
    Zhao H; Wei J; He Y; Wu Y; Ge L; Zheng C
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113952. PubMed ID: 38733646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoencapsulated Curcumin Mitigates Liver Injury and Drug-Metabolizing Enzymes Induction in Diclofenac-Treated Mice.
    Sunoqrot S; Abu Shalhoob M; Jarrar Y; Hammad AM; Al-Ameer HJ; Al-Awaida W
    ACS Omega; 2024 Feb; 9(7):7881-7890. PubMed ID: 38405487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic Acid-Conjugated Fluorescent Probe-Shielded Polydopamine Nanomedicines for Targeted Imaging and Chemotherapy of Bladder Cancer.
    Qiu H; Wang J; Zhi Y; Yan B; Huang Y; Li J; Shen C; Dai L; Fang Q; Shi C; Li W
    ACS Appl Mater Interfaces; 2023 Oct; 15(40):46668-46680. PubMed ID: 37769147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronic Acid-Based Nanoparticles for Protein Delivery: Systematic Examination of Microfluidic Production Conditions.
    Chiesa E; Greco A; Riva F; Dorati R; Conti B; Modena T; Genta I
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy.
    Laskar P; Dhasmana A; Kotnala S; Jaggi M; Yallapu MM; Chauhan SC
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery.
    Jurczyk M; Jelonek K; Musiał-Kulik M; Beberok A; Wrześniok D; Kasperczyk J
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33802531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Delivery of Gemcitabine for Precision Therapy of Cholangiocarcinoma Using Hyaluronic Acid-Modified Metal-Organic Framework Nanoparticles.
    Long C; Peng H; Yang W; Wang M; Luo B; Hao J; Dong Y; Zuo W
    ACS Omega; 2024 Mar; 9(10):11998-12005. PubMed ID: 38496964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Bioactive Disintegrable Polymer Nanoparticle for Synergistic Vascular Anticalcification.
    Adelnia H; Moonshi SS; Wu Y; Bulmer AC; Mckinnon R; Fastier-Wooller JW; Blakey I; Ta HT
    ACS Nano; 2023 Oct; 17(19):18775-18791. PubMed ID: 37650798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-drug (Curcumin/Ciprofloxacin) loading and release from chitosan-based hydrogels embedded with magnetic Montmorillonite/Hyaluronic acid for enhancing wound healing.
    Sayyar Z; Mahdavinia GR; Khataee A
    J Biol Eng; 2023 Oct; 17(1):66. PubMed ID: 37907952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery.
    Guo F; Fan Z; Yang J; Li Y; Wang Y; Zhao H; Xie L; Hou Z
    Nanoscale Res Lett; 2016 Dec; 11(1):384. PubMed ID: 27581601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programmable site-specific delivery of an alkaline phosphatase-activatable prodrug and a mitochondria-targeted cyclopeptide for combination therapy in colon cancer.
    Chen H; Yao Y; Zhao X; Tan N
    Biomater Sci; 2023 Oct; 11(21):7114-7123. PubMed ID: 37671612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases.
    Rao NV; Rho JG; Um W; Ek PK; Nguyen VQ; Oh BH; Kim W; Park JH
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 33003609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailoring tumor-recognizable hyaluronic acid-lipid conjugates to enhance anticancer efficacies of surface-engineered natural killer cells.
    Lee CE; Kim S; Park HW; Lee W; Jangid AK; Choi Y; Jeong WJ; Kim K
    Nano Converg; 2023 Dec; 10(1):56. PubMed ID: 38097911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combretastatin A4 phosphate encapsulated in hyaluronic acid nanoparticles is highly cytotoxic to oral squamous cell carcinoma.
    Sun C; Zhou Z; Liu F; Li H; Liu Z
    Arch Med Sci; 2024; 20(3):1022-1028. PubMed ID: 39050147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.